Ambry CancerNext Expanded CanNextEXP
Synonyms |
|
Allscripts (AEHR) Order Name |
Ambry CancerNext Expanded |
Sunrise Clinical Manager (SCM) Order Name |
Not Orderable |
EPIC Order Name |
|
Clinical Info |
Comprehensive, pan-cancer test for hereditary cancer predisposition, including genes associated with a wide range of hereditary cancers such as breast, ovarian, uterine, colorectal, gastric, pancreatic, prostate, melanoma, renal, central nervous system tumors, pheochromocytoma/paraganglioma, hematologic malignancy, and other rare cancer predisposition conditions. 77 genes are included in the analysis: AIP, ALK, APC, ATM, AXIN2, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, CEBPA, CHEK2, CTNNA1, DDX41, DICER1, EGFR, EPCAM, ETV6, FH, FLCN, GATA2, GREM1, HOXB13, KIT, LZTR1, MAX, MBD4, MEN1, MET, MITF, MLH1, MSH2, MSH3, MSH6, MUTYH, NF1, NF2, NTHL1, PALB2, PDGFRA, PHOX2B, PMS2, POLD1, POLE, POT1, PRKAR1A, PTCH1, PTEN, RAD51C, RAD51D, RB1, RET, RPS20, RUNX1, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4, SMARCB1, SMARCE1, STK11, SUFU, TMEM127, TP53, TSC1, TSC2, VHL, WT1 |
Specimen Type |
Blood, Swab |
Specimen Volume |
4mL |
Container |
Lavender Top Tube (EDTA whole blood) or Buccal Swab |
Collection Instructions |
Whole Blood |
Transport Instructions |
Room Temperature |
Specimen Stability |
|
Methodology |
Next Generation Sequencing (NGS) |
Days Performed |
Monday-Saturday |
Performing Laboratories |
|
CPT |
81432 or 81435 |
PDM |
255308 |
Result InterpretationSee Report |
|
Forms |
|